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Adrenogenital syndrome (AGS) is
the result of inborn enzymatic defects
in the synthesis of steroid hormones.
The production of cortisol is deficient
and that of adrenocorticotropic hor-
mone is increased. Sometimes male
patients have clinically detectable
testicular lesions, known as testicular
tumors of AGS (TTAGS). From 1985
to 1991, scrotal ultrasonography (US)
was performed in 30 consecutive pu-
bertal and postpubertal patients with
AGS to investigate the prevalence
and US characteristics of TTAGS.
Eight of 30 patients had a testicular
lesion (27%); six of the eight lesions
were clinically undetected. The mean
diameter of the lesions was 16.44 mm
(range, 2-28 mm). The lesions were
hypoechoic in all cases, with well-
defined margins in six cases. The
nodules were multifocal in all pa-
tients and bilateral in six (75%). If
testicular lesions are present in a pa-
tient with AGS, TTAGS are likely,
and frequent US monitoring is ade-
quate for diagnostic evaluation.
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DRENOGENITAL syndrome (AGS) is
the result of enzymatic defects
that are inherited as autosomal neces-
sive traits and result in deficient pro-
duction of cortisol and the accumula-
tion of hormonal precursors (1). The
frequency of AGS is approximately
one in 14,000 births (2). The most
common hormonal defect is a defi-
ciency of 21-hydroxylase, which oc-
curs in about 90% of the cases. While
1 1-hydroxylase and 17-hydroxylase
deficiencies have also been observed,
they are rare (5% and less than 1% of
cases, respectively) (3) (Fig 1). Defi-
ciency of 21-hydnoxylase has been
described as occurring in three forms:
a classic form with prenatal vinliza-
tion with on without salt wasting, a
late-onset form, and an asymptomatic
form (3).
Male patients can have testicular
lesions that manifest clinically, at pu-
berty or later, as an increase in the
size of the testis, often with a nodular
pattern (4). These lesions are known
as testicular tumors of AGS (flAGS)
(4). TTAGS are often bilateral and can
decrease in size when treated with
adequate hormonal therapy. Histo-
logically, TTAGS consist of focal areas
of endocrine cells that become hypen-
trophied after prolonged stimulation
with adrenocorticotropic hormone
(ACTH). It has been hypothesized
that the endocrine cells involved in
TTAGS resemble Leydig cells mom-
phologically but behave like adreno-
cortical cells (5). These testicular le-
sions can be a sign of poor hormonal
control, with the need for more ag-
gressive treatment (4).
While there are some clinical and
pathologic descniptions of these testic-
ular lesions in the literature, to our
knowledge there are only a few anti-
des describing their ultrasound (US)
characteristics (6,7). The frequency of
TTAGS in a population of living pa-
tients with AGS is unknown. In one
study none of the 52 men evaluated
had clinically detectable testicular
nodules (8), whereas in another study
all 14 men had histologic evidence of
TTAGS (9). These testicular masses
may pose diagnostic difficulties, espe-
cially when AGS is not considered,
and testicular biopsy and even orchi-
ectomy may be performed unneces-
sanily.
The aims of the present study were
to evaluate the clinical behavior of
these lesions, including patient age at
onset and tumor growth rates, as well
as the sonographic appearance of the
TTAGS.
MATERIALS AND METHODS
From January 1985 through June 1991,
we studied 30 consecutive male pubertal
or postpubertal patients with AGS (age
range, 9-32 years; mean, 17.8 years). The
clinical and laboratory data for these pa-
tients are summarized in Figure 2. Bio-
chemical confirmation of AGS (the cnite-
rion for selection of patients) consisted of
elevated serum levels of testosterone and
17-hydnoxyprogesterone and elevated un-
nary excretion of 17-ketosteroids and
pregnanetniol for the patients with 21-hy-
droxylase deficiency; il-hydnoxylase defi-
ciency was confirmed with assays of des-
oxycorticostenone and il-contisol.
Hormone control was assessed with
evaluation of assays of (a) 17-OH proges-
terone and (b) adnenoconticotnopic hom-
mone (ACTH) and findings of (c) bone age
and (d) growth charts. Hormone control
was classified as good, fair, or poor (1).
All 30 patients were examined with
scrotal ultrasound (US). For patients in
whom no abnormality was seen on the
initial scan, US scanning was repeated an-
nually. If the initial scan revealed patho-
logic changes, the patient underwent US
scanning every 3-6 months. US follow-up
of the patients ranged from 1 to 6 years
(mean, 3 years 1 month). Commercially
available US equipment was used (Toshiba
Medical Systems, Tokyo; CE Medical Sys-
tems, Milwaukee; and Ansaldo Medical
Abbreviations: ACTH = adrenocorticotropic
hormone, ACS = adrenogenital syndrome,
ITAGS = testicular tumors of AGS.
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Figure 1. Flow chart depicts metabolic pathway of the synthesis of aldosterone and cortisol.
Enzyme defects are in evidence. #{176}= hormonal precursors that accumulate, #{163}= hormone,
def = deficiency, OH-ASE = OH hydroxylase.
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Figure 2. Graph depicts hormone control on the basis of clinical and laboratory data of the
30 patients. 0 = normal testicles at US, #{149}= TTACS, o-#{149}= normal findings on initial US
scan that became positive in the follow-up US scan,  patients with 11-OH hydroxylase de-
ficiency.
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Systems, Genua, Italy) with high-fre-
quency linear probes (7.5 MHz). Scrotal U
scanning was performed in the longitudi/
nal, axial, and oblique planes, with use of
codified methods (10). A silicone pad
(Kitecko-3M, Malakoff, Cedex, France) was
applied to the scrotum to optimize visual-
ization of the superficial portions of the
testes. US examinations were always pen-
formed by a staff radiologist (PP., CC.)
with experience in pediatric radiology and
pediatric US. The presence, shape, num-
ben, and echogenicity of the lesions were
recorded and whether the lesions were
uni- or bilateral. Hard-copy scans were
obtained for further analysis; the images
were retrospectively reviewed by two ex-
aminers (A.V., PP.) in conference.
Findings at clinical and imaging fol-
low-up were considered the standard of
reference for the study. To differentiate
between testicular changes related to AGS
and to testicular malignancy, we consid-
ened the decrease in size on number of the
lesions after hormonal therapy to be evi-
dence of TTAGS. If the lesions were multi-
focal and showed either no change on
slight increase in size, follow-up of at least
I year was considered sufficient to rule
out a neoplasm.
RESULTS
US depicted testicular lesions in
eight of 30 patients with AGS (27%)
(Fig 2). In only two of these eight pa-
tients were the abnormalities clini-
cally palpable. The mean diameter of
the testicular lesions was 16.44 mm
(range, 2-28 mm). The clinical, bio-
chemical, and US data of the eight
subjects with flAGS are summarized
in the Table. Two patients of the
group with TTAGS (patients 1 and 2,
who were brothers) had 11-hydroxy-
lase deficiency. The other six patients,
who were not related, had 21-hydrox-
ylase deficiency. The age at detection
of testicular lesions varied from 10 to
21 years (mean, 15.6 years). The mean
age of the 22 patients without testicu-
lam lesions at US was 17 years (range,
9-32 years). Hormonal control was
poor in four of the eight patients
(50%) with TTAGS, compared with
control in six of 22 patients (27%)
without testicular lesions at US.
The nodules were always multifo-
cal (100%) and often bilateral (pa-
tients 1-6 [75%]). The location was
intratesticular in all cases; one patient
also had two apparently extratesticu-
lam lesions, in the epididymis (Fig 3).
The testicular lesions revealed at US
were always hypoechoic but only
mildly hypoechoic in three cases. In
one case a hyperechoic rim was de-
tected (Fig 4). The margins were well
defined in six cases (Fig 5) and were
blurred in the other two.
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The characteristics of the eight pa-
tients who had positive US findings
for flAGS include the following data.
Patient 1 was first examined in 1987,
when he was 24 years old. At that
time, bilateral multifocal lesions with
a clinically palpable testicular nodular
pattern were seen at US. Findings
from a previous US examination per-
formed at another institution in 1982
(when the patient was 18 years old)
were of bilateral nodular lesions. Pa-
tient 2 underwent his first US exami-
nation in 1981, at another institution,
when the boy was 11 years old; find-
ings in this examination were re-
ported to be positive. In 1987 a US
examination performed at our institu-
tion confirmed the presence of bilat-
emal hypoechoic lesions in the testes
and the epididymis (Fig 3).
Patient 3 underwent scrotal US
scanning at another institution in
TESTOSTERONE#{176}
1982; findings were reported as non-
mal. In 1987, when he was 10 years
old, a US scan depicted bilateral hy-
poechoic foci located near the testicu-
lar hilum. These abnormalities did not
change in the 4 years of follow-up
(Fig 6). Patients 4 and 5 underwent
their first US examinations in 1988 (at
ages 16 and 15 years, respectively).
flAGS were diagnosed in each. Pa-
tient 4 was the only one in whom the
follow-up US scans revealed an in-
crease in the size of the lesions (from
19 mm to 21 mm in 3 years). Biopsy
was not performed of these lesions
because this small increase in size was
not considered significant. Hormonal
control was good in this patient.
Findings at US in patient 6 were
negative in January 1989 (when the
patient was 16 years old). One year
later bilateral testicular involvement
was apparent clinically and at US.
Clinical and Sonographic Aspects of Eight Children with Testicular Lesions
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Age (y) Age (y)
at First at Prior TTAGS Range in Size
Patient
No.
Positive
US Scan
Negative
US Scan0
Clinically
Present
Hormonal
Control
of Tumor
(mm) Bilateral Multifocal
Years of
Follow-up
Findings at
Follow-up*
it 18 NA Yes Poor 7-25 Yes Yes 5.0 No change
2 11 NA No Poor 14-20 Yes Yes 6.0 No change
3 10 5 No Poor 10-20 Yes Yes 4.0 No change
4 16 NA No Good 11-19 Yes Yes 3.0 Mild increase in
diameter (to
21 mm)
5 15 NA No Poor 2-6 Yes Yes 3.0 No change
6 17 16 Yes Good 26-28 Yes Yes 1.5 Mild decrease in
diameter (to
18 mm)
7 21 19 No Fair 3-4 No Yes 1.5 No change
8 17 16 No Good 3-5 No Yes 1.0 No change
0 NA = not applicable.
t Patients with 11-OH hydroxylase deficiency.
Figure 3. Patient 2. Oblique sonogram
shows lesions (cursors) in both the testis and
the tail of the epididymis (arrowheads).
Figure 4. Patient 1. Longitudinal sonogram
of the right testis shows multifocal hypo-
echoic lesions with blurred margins and
echogenic rim (arrows).
During follow-up for 1V2 years, the le-
sions decreased in size after treatment
with appropriate hormonal therapy.
At the patient’s last US examination,
the diameter of the lesions had de-
creased from 26 x 9 mm to 18 x 6 mm
and from 28 x 9 mm to 17 x 7 mm.
Two of the eight patients (patients
7 and 8 [25%]) had unilateral multiple
lesions. In patient 7 testicular US
scans were negative from 1987 through
1989, but multiple small ( < 4-mm-di-
ametem) hypoechoic lesions were de-
tected at US in one testis in 1990,
when the patient was 21 years old.
Findings at US examinations were
negative for the 1st year in patient 8;
in the 2nd year, when the patient was
17 years old, US examination revealed
two small hypoechoic foci ( < 5 mm in
diameter) in the right testis.
DISCUSSION
The most common inborn enzy-
matic defect that causes AGS is 21-
hydroxylase deficiency, which has
been described as existing in three
forms: a classic form with prenatal
virilization with or without salt wast-
ing, a late-onset form, and an asymp-
tomatic form. Other enzyme defects
are rare and sometimes do not result
in vimilization (1).
Some pubertal or postpubertal male
patients with AGS have clinically de-
tectable testicular masses that must be
differentiated from malignancy (4)
because they are completely benign,
with no malignant potential. It has
been known for 40 years that testicu-
lam “ tumors” occur in patients with
AGS (11), but there is considerable
controversy about the origin of these
tumorlike lesions. Although some au-
thoms have called the lesions ectopic
adrenal tissues (11), others believe
that they represent Leydig cells (12).
The biochemical resemblance of the
tumor cells to those of the associated
hyperplastic adrenal cortex lends sup-
port to the theory of origin in adrenal
cortical rests. Adrenal cortical rests,
found in the vicinity of the testis in
7.5%-15.0% of newborn (13) and 1.6%
of adult testes (14), are predominantly
extratesticular (13). This location is a
finding that supports the argument
against the rests giving rise to TTAGS,
since TTAGS are intratesticular in
95% of cases (15). In our experience,
all lesions were intratesticular, except
in patient 2, who also had extratestic-
ulam lesions.
Regardless of the origin, TTAGS are
caused by elevated levels of ACTH,
and similar testicular lesions can be
found in patients with other condi-
tions, such as Addison disease and
Cushing syndrome, that are also char-
actenized by elevated levels of ACTH
(6). TTAGS may pose diagnostic diffi-
culties both clinically and pathologi-
cally. If AGS is not taken into account,
a testicular mass is usually assumed to
be a neoplasm, and an orchiectomy
may be performed (4). At other times
the diagnosis of AGS may not be
made until a testicular mass develops;
in a study of 40 patients with AGS this
was the case in seven patients (18%)
(15). At histologic examination the
lesions may be misinterpreted to be a
Leydig cell tumor (15). In 1953 Prader
demonstrated that the testicular
masses are not autonomous neo-
plasms but are dependent on the ele-
vated level of ACTH that occurs in
patients with AGS and that the
masses decrease in size if the level of
ACTH is lowered by the administra-
tion of conticosteroids (16).
It is difficult to establish on clinical
grounds the frequency of testicular
tumors in patients with AGS. In one
study none of 52 adult male patients
had testicular nodules (8), whereas
nine of 17 male patients (53%) were
a. b.
Figure 5. Patient 3. (a) Longitudinal sonogram of the right testis and (b) longitudinal and
axial sonograms of the left testis show bilateral multifocal hypoechoic lesions with sharp mar-
gins (cursors).
a. b.
Figure 6. Patient 2. (a) Oblique sonograms obtained in 1987 and (b) sagittal sonogram ob-
tamed in 1989 show the diameter of the testicular lesion (cursors) to be unchanged in this time
period.
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found to have testicular nodules at
clinical examination in another study
(17). The prevalence appears to be
related to hormonal control and to
the age of the patients: The lesions
that were detected clinically devel-
oped during periods of inadequate
hormonal therapy as a result of low
dosage or poor compliance (4). In a
recent investigation (7), however,
scrotal US scanning revealed testicu-
lam lesions in seven of 15 (47%) male
patients with AGS who were not in
poor hormonal control. Clinical pal-
pation revealed testicular changes in
six of these patients.
The purposes of the present study
were to assess the frequency of
flAGS in a population of living AGS
patients who were screened with US
and to describe the sonographic pat-
temns of the lesions. The prevalence of
TTAGS in our study was 27%. No pa-
tient had the late-onset form of AGS.
The majority of TTAGS were discov-
ered in patients between the ages of
10 and 20 years (Fig 1). Normal US
scans had been obtained in those pa-
tients as recently as 1 year prior to
observation of the TTAGS, indicating
that annual surveillance is probably
appropriate during this period. Nega-
tive findings at US do not preclude
future development of the lesions, but
once the lesions develop they are mel-
atively slow growing. In our study,
four of the eight patients with testicu-
lam lesions had poor hormonal con-
trol, but only two had clinical evi-
dence of the lesions and in one of
these (patient 6) hormonal control
was good (Table). On the other hand,
only 27% of the patients without
TTAGS depicted at US were in poor
hormonal control. These data suggest
that testicular nodules detected at US
occur frequently and that poor com-
pliance with hormonal therapy is
found in approximately one-half of
the patients with testicular nodules.
The diameter of the lesions in pa-
tient 4 increased slightly in the fol-
low-up period. The patient complied
well with treatment, and the increase
could not be attributed to poor hor-
monal control. The increase might
have been the result of partial auton-
omy of the nodule, and the patient is
now examined more frequently. Pa-
tient 6 was treated aggressively with
steroids, and the lesions decreased in
diameter from approximately 3 cm to
less than 2 cm in 1 year. The lesions in
the other six patients did not change
in size during follow-up, despite hor-
monal control that was poor in four
patients and good to fair in two.
One important finding that enables
establishment of a correct diagnosis of
TTAGS is the US pattern of the le-
sions. In our experience the nodules
were always multifocal, were bilateral
in six of eight patients, and were al-
ways hypoechoic. The margins were
well defined in six patients. Testicular
neoplasms, on the contrary, are fre-
quently solitary lesions (10). When
multifocal, neoplasms are located in
only one testis: Bilateral multifocal
testicular malignancy is rare (10).
The US aspects of the lesions in our
patient population are similar to those
described in the study of Seidenwurm
et al (6), except that we did not find
the acoustic shadowing pattern that
was present in all their patients. This
finding can be partially explained by
the differences in the two popula-
tions. The mean age of the patients
studied by Seidenwunm et al was 19.7
years, while the mean age of our pa-
tients was 15.6 years. Furthermore
one of the patients studied by Seiden-
wurm et al had Addison disease. The
sonographic pattern described by
Willi et al (7) was similar to that ob-
served in our patients.
At pathologic examination, the ma-
jor lesion to be distinguished from
TTAGS is the Leydig cell tumor, be-
cause the cells of both lesions look
similar. However, this distinction can
be determined histologically (4): At
microscopic examination the abun-
dant septa, composed of dense con-
nective tissue, that surround lobules
in TTAGS are rarely seen in Leydig
cell tumors, which generally have
thin septa composed of connective
tissue. Moreover, the cytoplasm is
more copious in TTAGS. Only 3% of
Leydig cell tumors are bilateral (18)
compared with 75% of TTAGS in our
study. Furthermore, Leydig cell tu-
mors are usually seen in patients in
their 3rd through 6th decade com-
pared with TTAGS seen in our pa-
tients in their 2nd decade. Finally,
some bilateral “Leydig cell tumors”
have proved to be TTAGS at careful
endocrinologic investigation (19).
None of our patients had Leydig cell
tumors.
We did not assess the fertility of our
patients because most of them were in
their teens. Some authors (5) describe
an association of TTAGS and poor
fertility in patients with AGS. In some
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patients they report return of fertility
and disappearance of the testicular
masses after low-dose suppressive
therapy with dexamethasone.
The presence of the clinical features
of AGS is a major clue to the correct
diagnosis. When bilateral, multifocal,
hypoechoic testicular lesions are de-
tected at scrotal US scanning, how-
ever, the possibility of AGS should be
investigated, even in the absence of
clinical symptoms. In fact, in one
study of 40 patients with clinically
detectable flAGS (4), AGS was not
diagnosed in 18% of the patients until
the development of a testicular mass.
Consequently, if multifocal and bilat-
eral lesions are detected in a young
boy, AGS should be kept in mind.
Conversely, if multifocal testicular
lesions are present in the testis of a
patient with AGS (7), TTAGS are
likely and frequent US follow-up is
adequate for the diagnosis.
In conclusion, since most intrates-
ticular lesions in young adults are ma-
lignant (10), it is important to recog-
nize that bilateral, multifocal,
hypoechoic nodules in the testes of
patients with AGS are probably
TTAGS. As the size of these lesions
decreases or remains stable during
hormonal therapy, further investiga-
tion may be limited to clinical and US
follow-up. The greaten sensitivity of
US compared with clinical evaluation
in the detection of tiny multifocal le-
sions can help rule out malignancy;
thus, testicular biopsy need be per-
formed in only those patients with
lesions that show a rapid increase in
size. I
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